Assistant Professor of Surgery, Massachusetts General Hospital
General Surgery
Dr. Cristina R. Ferrone, MD
|
|
Give Review
Cristina Ferrone works in the field of General Surgery. She went to medical school at Washington University School of Medicine in St. Louis. She over the years received 1 awards: "Fellow (FACS)". Cristina Ferrone is also published. She has 99 publications published. The lastest publication: "Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma.' Cristina Ferrone is registered with Medicare and accepts Medicare payments.
Publications
- Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma.
- Primary Hepatic Gastrinoma.
- Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors.
- Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms.
- Acute pancreatitis in intraductal papillary mucinous neoplasms: A common predictor of malignant intestinal subtype.
- Patterns of Recurrence After Resection of IPMN: Who, When, and How?
- Erratum to: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.
- Microsatellite instability in gallbladder carcinoma.
- The Charlson age comorbidity index predicts early mortality after surgery for pancreatic cancer.
- Early Drain Removal-The Middle Ground Between the Drain Versus No Drain Debate in Patients Undergoing Pancreaticoduodenectomy: A Prospective Validation Study.
- Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.
- The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.
- In response to Birgir Gudjonsson, MD.
- High performing whipple patients: factors associated with short length of stay after open pancreaticoduodenectomy.
- Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumors.
- Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: Implications of minimal involvement of the main pancreatic duct.
- Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells.
- Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer.
- Compression of pancreatic tumor blood vessels by hyaluronan is caused by solid stress and not interstitial fluid pressure.
- Blocking the formation of radiation-induced breast cancer stem cells.
- Genomic Profiling of Intrahepatic Cholangiocarcinoma: Refining Prognosis and Identifying Therapeutic Targets.
- IPMN Involving the Main Pancreatic Duct: Biology, Epidemiology, and Long-Term Outcomes Following Resection.
- A Phase 1/2 and Biomarker Study of Preoperative Short Course Chemoradiation With Proton Beam Therapy and Capecitabine Followed By Early Surgery for Resectable Pancreat...
- PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation.
- A Nomogram to Predict Long-term Survival After Resection for Intrahepatic Cholangiocarcinoma: An Eastern and Western Experience.
- Lymphadenectomy for pancreatic neuroendocrine tumors: is that the relevant debate?
- Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma.
- Reply to Letter: "Retrospective Studies and Pancreatic Adenocarcinoma: How Far Can We Backdate?"
- Phase I study of neoadjuvant accelerated short course radiation therapy with photons and capecitabine for resectable pancreatic cancer.
- Surgery for Small and Asymptomatic Branch-Duct IPMNs.
- Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Mas...
- Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines...
- Emerging BRAF inhibitors for melanoma.
- Understanding Hospital Readmissions After Pancreaticoduodenectomy: Can We Prevent Them? : A 10-Year Contemporary Experience with 1,173 Patients at the Massachusetts Ge...
- Recurrence after operative management of intrahepatic cholangiocarcinoma.
- Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.
- BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma.
- N0/N1, PNL, or LNR? The Effect of Lymph Node Number on Accurate Survival Prediction in Pancreatic Ductal Adenocarcinoma.
- Does Autoimmune Pancreatitis Increase the Risk of Pancreatic Carcinoma?: A Retrospective Analysis of Pancreatic Resections.
- Acinar cystadenoma of the pancreas: a clinicopathologic study of 10 cases including multilocular lesions with mural nodules.
- Pancreatic Ductal Adenocarcinoma: Is There a Survival Difference for R1 Resections Versus Locally Advanced Unresectable Tumors? What Is a "True" R0 Resection?
- Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors.
- Short-term Outcomes in Obese Patients after Colectomy for Adenocarcinoma at a Bariatric Center.
- Targeting the MAGE A3 antigen in pancreatic cancer.
- 851 resected cystic tumors of the pancreas: A 33-year experience at the Massachusetts General Hospital.
- Evolution of the Whipple procedure at the Massachusetts General Hospital.
- Pancreatic ductal adenocarcinoma: Long-term survival does not equal cure.
- Intraductal papillary mucinous neoplasms: Does a family history of pancreatic cancer matter?
- Cystic papillary pattern in pancreatic ductal adenocarcinoma: a heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma.
- Gallbladder lesions identified on ultrasound. Lessons from the last 10 years.
- Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex.
- Cytology Adds Value to Imaging Studies for Risk Assessment of Malignancy in Pancreatic Mucinous Cysts.
- Superior prognostic importance of perineural invasion vs. lymph node involvement after curative resection of duodenal adenocarcinoma.
- A duodenal duplication cyst causing recurrent pancreatitis in a young patient.
- Targeting ALDHbright human carcinoma initiating cells with ALDH1A1- specific CD8+ T cells.
- Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment.
- Twenty-three years of the warshaw operation for distal pancreatectomy with preservation of the spleen.
- Implications of Incidentally Discovered, Nonfunctioning Pancreatic Endocrine Tumors: Short-term and Long-term Patient Outcomes.
- Metastatic tumors in the pancreas in the modern era.
- Cholesterol crystal embolization presenting as either solid or cystic pancreatic lesion.
- Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function.
- Case records of the Massachusetts General Hospital. Case 19-2010. A 35-year-old man with adenocarcinoma of the cecum.
- Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio.
- Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?
- Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator ph...
- Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of ...
- Current trends in pancreatic cystic neoplasms.
- Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience.
- BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma.
- Why do patients with low-grade soft tissue sarcoma die?
- Pancreatic fistula rates after 462 distal pancreatectomies: staplers do not decrease fistula rates.
- Preoperative platelet count and survival prognosis in resected pancreatic ductal adenocarcinoma.
- Pancreatic adenocarcinoma: the actual 5-year survivors.
- Mechanisms of immunization against cancer using chimeric antigens.
- Vascular and biliary variants in the liver: implications for liver surgery.
- Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital.
- Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified?
- Extrahepatic bile duct carcinoid tumors: malignant biliary obstruction with a good prognosis.
- The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma.
- Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains.
- Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.
- Limitations of ampullectomy in the treatment of nonfamilial ampullary neoplasms.
- Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival.
- Clinicopathological features of and risk factors for multiple primary melanomas.
- A single heteroclitic epitope determines cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigen.
- Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status.
- Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligo.
- Clinicopathologic correlates of solitary fibrous tumors.
- Strategies to overcome immune ignorance and tolerance.
- Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapy.
- Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAF(V600E) melanoma.
- Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control.
- Incidental pancreatic cysts: do we really know what we are watching?
- CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model sy...
- Dual roles for immunity in gastrointestinal cancers.
- Implications and management of pancreatic fistulas following pancreaticoduodenectomy: the Massachusetts General Hospital experience.
- Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance.
- Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma.
Schools
Washington University In St Louis School Of Medicine
Massachusetts General Hospital
Memorial Sloan Kettering Cance
Doctors Specialties
- Surgery
- General Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
Massachusetts General Hospital -
Washington University School of Medicine in St. Louis
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1316053192 | |
| NPPES Provider LastName | FERRONE | |
| NPPES Provider FirstName | CRISTINA | |
| NPPES Provider ZIPCode | 021144161 | |
| NPPES Provider State | MA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 24.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316053192 |
| Last Name Of The Provider | FERRONE |
| First Name Of The Provider | CRISTINA |
| View All |
Similar Doctors
|
|
Dr. Carrie F. Spangler, MD |
|
|
Dr. Jonathan Young, MDCM |
|
|
Tammy M. Holm |
|
|
Dr. Michael T. Grant, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jabaris D. Swain, MD |
|
|
Dr. Margarita S. Ramos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicole A. Kissane, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Salim Afshar, MD |
|
|
Dr. John T. Mullen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yohei Yamada, MD
This Doctor is OpenDoctor Recommended.
|